Relationship between salivary Chromogranin-A and stress induced by simulated monotonous driving

Medical and Biological Engineering and Computing

Volumn 47, Issue 4, 2009, Pages 449-456

  Yamakoshi, Takehiro ^a   Park, Sang Bum ^a   Jang, Won Cheoul ^b   Kim, Kyungho ^b   Yamakoshi, Yasuhiro ^c   Hirose, Hajime ^d  

^a KANAZAWA UNIVERSITY   (Japan)

^b Dankook University   (South Korea)

^c CHIBA UNIVERSITY   (Japan)

^d KINJO UNIVERSITY   (Japan)

Author keywords

Cardiovascular monitoring; Monotonous driving; Salivary Chromogranin A; Stress

Indexed keywords

CARDIAC OUTPUTS; CARDIOVASCULAR MONITORING; CHROMAFFIN; CONTROLLED CONDITIONS; EXTRA-CELLULAR ENVIRONMENTS; INDUCED STRESS; MENTAL STRESS; MONOTONOUS DRIVING; SALIVARY CHROMOGRANIN-A; STRESS-INDUCED; SUBJECTIVE RATINGS; SYMPATHETIC ACTIVITIES; TOTAL PERIPHERAL RESISTANCES;

AMINES; BLOOD PRESSURE; BLOOD VESSELS;

ABERRATIONS;

ADOLESCENT; ADULT; AUTOMOBILE DRIVING; BIOLOGICAL MARKERS; BOREDOM; CHROMOGRANIN A; FEMALE; HUMANS; MALE; SALIVA; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 62649116383     PISSN: 01400118     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11517-009-0447-y     Document Type: Article

References (36)

1. Blaschko H, Comline RS, Schneider FH, Silver M, Smith AD (1967) Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 215:58-59. doi: 10.1038/215058a0
2. Deboer RW, Karemaker JM, Strackee J (1987) Hemodynamic fluctuations and baroreflex sensitivity in humans: A beat-to-beat model, Am J Physiol 253 (Heart Circ Physiol 22):680-689
3. Den R, Toda M, Nagasawa S, Kitamura K, Morimoto K (2007) Circadian rhythm of human salivary CgA. Biomed Res 28(1):57-60. doi: 10.2220/ biomedres.28.57
4. Fangwen R, Gen W, Jiaur RG, Madhusudan D, Vaingankar SM, Rana BK, Mahata M, Kennedy BP, Rany M, Salem MPH, Stridsberg M, Abel K, Smith DW, Eleazar EE, Schork NJ, Hamilton BA, Ziegler MG, Mahata SK, O'Connor DT (2007) Catecholamine release-inhibitory peptide catestatin (chromogranin A352-372) naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation 115:2271-2281. doi: 10.1161/ CIRCULATIONAHA.106.628859
5. Fujimoto S, Nomura M, Niki M, Motoba H, Ieishi K, Mori T, Ikefuji H, Ito S (2007) Evaluation of stress reactions during upper gastrointestinal endoscopy in elderly patients: Assessment of mental stress using chromogranin A. J Med Invest 54(1, 2):140-145
6. Hakkanen H, Summala H (2001) Fatal traffic accidents among trailer truck drivers and accident causes as viewed by other truck drivers. Accid Anal Prev 32:187-196. doi: 10.1016/S0001-4575(00)00030-0
7. Kakizaki T, Oka T, Kurimori S (1992) Changes in mental workload and fatigue during performance of a mental task. Jpn J Ind Health 34:565-573
8. Kim T, Loh YP (2005) Chromogranin A: A surprising link between granule biogenesis and hypertension. J Clin Invest 115(7):1711-1713. doi: 10.1172/JCI25706
9. Kim T, Tao-Cheng JH, Eiden LE, Loh YP (2001) Chromogranin A, an "on/ off" switch controlling dense-core secretory granule biogenesis. Cell 106:499-509. doi: 10.1016/S0092-8674(01)00459-7
10. Kirschbaum C (1964) Salivery cortisol in psychoneuroendocrine research; recent developments and applications. Pshychoneuroendocriology 19:313-333. doi: 10.1016/0306-4530(94)90013-2
11. Kuhm CM (1989) Handbook of research methods in cardiovascular behavioral medicine. Plenum, New York
12. Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ (1997) Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100:1623-1633. doi: 10.1172/JCI119686
13. Mahata SK, Mahata M, Parmer RJ, O'Connor DT (1999) Desensitization of catecholamine release: The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364) acts at the receptor to prevent nicotinic cholinergic tolerance. J Biol Chem 274:2920-2928. doi: 10.1074/jbc.274.5.2920
14. Mahata SK, Mahata M, Wakade AR, O'Connor DT (2000) Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): Identification of amino acid residues crucial for activity. Mol Endocrinol 14:1525-1535. doi: 10.1210/me.14.10.1525
15. Mahata SK, Mahata M, Wen G, Wong WB, Mahapatra NR, Hamilton BA, O'Connor DT (2004) The catecholamine release-inhibitory "catestatin" fragment of chromogranin A: Naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses. Mol Pharmacol 66(5):1180-1191. doi: 10.1124/mol.104.002139
16. Nakae H, Asami O, Yamada Y, Harada T, Matsui N, Kanno T, Yanaihara N (1998) Salivary chromogranin A as an index of psychosomatic stress response. Biomed Res 19:401-406
17. Nakagawara M, Yamakoshi K (2000) A portable instrument for non-invasive monitoring of beat-by-beat cardiovascular haemodynamic parameters based on the volume-compensation and electrical-admittance method. Med Biol Eng Comput 38:17-25. doi: 10.1007/BF02344683
18. RING C (2000) Secretory immunoglobulin A and cardiovascular reactions to mental arithmetic, cold pressor, and exercise: Effects of alpha-adrenergic blockade. Psychophysiology 37:634-643. doi: 10.1017/ S0048577200991030
19. Sawada Y, Tanaka G, Yamakoshi K (2001) Normalized pulse volume (NPV) derived photo-plethysmographically as a more valid measure of the finger vascular tone. Int J Psychophysiol 41:1-10. doi: 10.1016/ S0167-8760(00)00162-8
20. Sushi K, O'Connor DT, Manjula M, Yoo SH et al (1997) Novel autocrine feedback control of catecholamine release: A discrete chromogranin A fragment is a noncompetitive nicotinic cho linergic antagonist. J Clin Invest 100(6):1623-1633. doi: 10.1172/JCI119686
21. Takiyyuddin MA, De Nicola L, Gabbai FB, Dinh TQ, Kennedy B, Ziegler MG, Sabban EL, Parmer RJ, O'Connor DT (1993) Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension. Hypertension 21:674-679
22. Taylor CV, Taupenot L, Mahata SK, Mahata M, Wu H, Yasothornsrikul S, Toneff T, Caporale C, Jiang Q, Parmer RJ, Hook VYH, O'Connor DT (2000) Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. J Biol Chem 275:22905-22915. doi: 10.1074/ jbc.M001232200
23. Thiffault P, Bergeron J (2003) Monotony of road environment and driver fatigue: A simulator study. Accid Anal Prev 35:381-391. doi: 10.1016/ S0001-4575(02)00014-3
24. Toroyan and Peden (2007) In: T. Toroyan and M. Peden (eds) Youth and Road Safety, World Health Organization Report, Geneva. Accessible at http://www.who.int/violence_injury_prevention/publications
25. Tsigelny I, Mahata SK, Taupenot L, Preece NE, Mahata M, Khan I, Parmer RJ, O'Connor DT (1998) Mechanism of action of chromogranin A on catecholamine release: Molecular modeling of the catestatin region reveals a b-strand/loop/bstrand structure secured by hydrophobic interactions and predictive of activity. Regul Pept 77:43-53. doi: 10.1016/S0167-0115(98)00040-8
26. Tsujita S, Morimoto K (1999) Secretory IgA in saliva can be a useful stress marker. Environ Health Prev Med 4(1):1-8. doi: 10.1007/BF02931243
27. Von Euler U (1964) Quantification of stress by catecholamine analysis. Clin Pharmacol Ther 5:398-404
28. Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L (1971) 24 Hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 33:14-22
29. Wu HJ, Rozansky DJ, Parmer RJ, Gill BM, O'Connor DT (1991) Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression. J Biol Chem 266:13130-13134
30. Yamaguchi M, Kanemori T, Kanemaru M, Mizuno Y, Yoshida H (2001) Correlation of stress and salivary amylase activity. Iyodenshi To Seitai Kogaku 39:234-239
31. Yamakoshi K (2003) Non-invasive cardiovascular haemodynamic measurements. In: Oberg PA, Togawa T, Spelman F (eds) Sensors in medicine and health care (sensors applications), vol 3. Wiley, Weinheim, pp 107-160
32. Yamakoshi K, Nakagawara M, Tanaka T (2000) Current development in beat-by-beat cardiovascular monitoring with non-invasive and ambulatory techniques. In: Singh M, Radhakrishnan S, Ratil KM, Reddy MRS (eds) Medical diagnostic techniques and procedures. Narosa Publishing House, New Delhi, pp 132-141
33. Yamakoshi T, Yamakoshi K, Tanaka S, Nogawa M, Sawada Y, Rolfe P (2006) Hemodynamic responses during simulated automobile driving in a monotonous situation. In: Proceedings 28th Annual International Conference of the IEEE Engineering in Medicine and Biology, New York, 5129-5132
34. Yamakoshi T, Rolfe P, Yamakoshi Y, Hirose H (2009) A novel physiological index for driver's activation state derived from simulated monotonous driving studies. Transp Res C 17(1):69-80
35. Yerkes RM, Dodson JD (1908) The relation of strength of stimulus to rapidity of habit-formation. J Comp Neurol Psychol 18:459-482. doi: 10.1002/cne.920180503
36. Yoo SH, Albanesi JP (1991) High capacity, low affinity Ca2φ binding of chromogranin A. Relationship between the pH-induced conformational change and Ca2φ binding property. J Biol Chem 266(12):7740-7745